chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My vaccine was administered at 12:30pm. I waited until 12:55 at CVS after the vaccine to make sure there were no reactions. I also move my arm around a lot after the injection to keep it from hurting. I drove home, at lunch and about 2:45 was hit with a very noticeable headache. I never get headaches and eat healthy and consume about a gallon of water a day. I knew it wasn't from dehydration or being hungry.  Headache was in the temple area and made my eyes hurt in the same way they would if you had cried for an extended period of time or were overtired. At 3pm a wave of exhaustion hit me. I was sitting working trying to combat the headache and felt almost wiped out. I got through the rest of my work day (4:30) and went to lay down immediately. I passed out almost instantly until 7 pm. I work up and showered, ate dinner and started to feel a little warm. It should be noted it was an unseasonably warm day and got up to 77, so it was a tiny bit warm in my home. I put on loose fitting clothes and slayed on the couch still with the bad headache and the injection site started to throb so I placed and ice pack on for 20 minutes. I could only stay awake until 8:45 and got in bed. I could not get comfortable for several hours feeling very warm. I tried a fan on high and drinking more water but i felt very warm like how you feel with the flu. I took my temp at 1130pm it was normal. I continued to toss and turn and feel very warm and slightly dizzy, in the sense that I hadn't been able to sleep and with the headache my body was just exhausted. Around 2 am i woke up for more water and got in the shower because I had sweated so much my sheets were wet and my clothes. I got out of the shower around 10 minutes later, changed and got new sheets and got back in bad. Around 330 I felt very hot again and opened the windows and got another ice pack for my arm which was throbbing again. I finally fell asleep after 3:45am. I got up for work at 6am. I felt slightly foggy, and very hot. But no fever. My temp is normally around 97.4-97.9 and it was 98.4. Still normal but I was running warmer than usual. It took a long time to get ready and despite hot water in the shower I was freezing. i got dress and debated going to work. Got in the car at 6:45 and my drive to work is 30 minutes. 1/2 way into my drive I got very sweaty again and went home to change my clothes because they were too warm. Got to work around 7:20 and still felt warm but they take our temps at the door and min was still okay, no fever. I drank a lot of water and ate, and at 8:30 am all of a sudden the exhaustion was gone and I felt normal. I got home form work at 5:30p and took a 3 hour nap and felt normal again.
rash (spreading quickly) chest, neck and lips. Evaluated by EMS-Transported to Emergency room/department or urgent care.
Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Family history included Autoimmune disorder (large family history of autoimmune diseases.) and Allergy to antibiotic (Allergy to several antibiotics) since an unknown date. Concurrent medical conditions included Penicillin allergy and Drug allergy (Allergy to sulfones). Concomitant products included MELOXICAM from 12-Mar-2021 to an unknown date for Bursitis, PREGABALIN (LYRICA), ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID; CALCIUM; MINERALS NOS; RETINOL; TOCOPHERYL ACETATE; VITAMIN B NOS; VITAMINS NOS; ZINC]) and HYDROXYZINE for an unknown indication.   On 02-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 04-Feb-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-079514 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up received on 20-MAY-2021 included reporter details physician details. Updated patient demographic details, Vaccination time, Concomitant medication information. On 20-May-2021: ADR & hypersensitivity forms returned. NNI, duplicate information received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079514: cross link to Dose 2
This 23-month-old male received 4 doses of Haemophilus b conjugate vax. Subsequent to the 4th vax on 11/30/1995, the pt developed meningitis due to vax failure. At the time of reporting the pt's outcome was "yes." The pt's experience was considered "an other medical event." No further information is available.
Arm was very sore; fatigued; nauseous; lightheaded; vomiting; hard to eat; bowel movement is slow; doesn't feel like themselves; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Arm was very sore), FATIGUE (fatigued), NAUSEA (nauseous), DIZZINESS (lightheaded) and VOMITING (vomiting) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Arm was very sore), FATIGUE (fatigued), NAUSEA (nauseous), DIZZINESS (lightheaded), VOMITING (vomiting), EATING DISORDER (hard to eat), BOWEL MOVEMENT IRREGULARITY (bowel movement is slow) and FEELING ABNORMAL (doesn't feel like themselves). At the time of the report, MYALGIA (Arm was very sore), FATIGUE (fatigued), NAUSEA (nauseous), DIZZINESS (lightheaded), VOMITING (vomiting), EATING DISORDER (hard to eat), BOWEL MOVEMENT IRREGULARITY (bowel movement is slow) and FEELING ABNORMAL (doesn't feel like themselves) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug details were reported. No treatment details were reported.   Reporter did not allow further contact
This is a spontaneous report received from contactable consumer or other non-HCP (patient). A 38-year-old female patient (not pregnant) received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# ER8734), at the age of 38, in left arm, on Apr 1, 2021, at 12:30, single dose, for COVID-19 immunisation. Medical history included allergies: Omnipaque (contrast dye) (unspecified if ongoing). Concomitant medications included vitamin C. The patient felt hot (hot, warm shot running from right pelvis down to right leg), onset Apr 1, 2021, at 20:00, with outcome of not recovered. The event evaluated at a physician office visit. Therapeutic measures were taken. Additional information: The patient did not take any other vaccine in four weeks. The patient took multivitamin and vitamin C in two weeks. The patient neither had COVID-19 prior vaccination, nor  tested for COVID-19 post vaccination. Follow-up attempts completed. No further information expected.
Onset of nausea, vomiting (~6 episodes) & related symptoms of vertigo began about 0600h on 7/3. Presented to ED for eval/treat. Basic workup done - no abnormal labs noted. Given ondansetron & meclizine in ED and symptoms decreased enough for patient to agree to be discharged to home.  Later in the morning on 7/3, patient began experiencing fever & chills (did not take her own temp), which resolved by evening.
Headache, Myalgia, Fever, fatigue, axillary pain, pharyngitis, nasal congestion Narrative:
Covid arm came and went; Sunburn that came and went; Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm came and went), SUNBURN (Sunburn that came and went) and LYMPHADENOPATHY (Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm came and went), SUNBURN (Sunburn that came and went) and LYMPHADENOPATHY (Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck). At the time of the report, VACCINATION SITE REACTION (Covid arm came and went) and SUNBURN (Sunburn that came and went) had resolved and LYMPHADENOPATHY (Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
After having received the second dose within 12 hours began to have a reoccurrence of a shingles attack on the lower right half side of back.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included shingles and allergy to metal staple. Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 01:00, within 12 hours after receiving the second dose the patient experienced a reoccurrence of a shingles attack on the lower right half side of back. The patient had shingles before but knew from past experience it was a result of a stressful experience. The patient had a prescription for valeted and was ok. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event. The clinical outcome of the event reoccurrence of a shingles attack on the lower right half side of back was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Friday I got the shot at 10:35 - about 40 minutes later I started to cough very badly until I could not breathe. I could not get air into or out of my throat. the coughing lasted about 15 minutes and the loss of breath lasted seconds but happened twice one after the other. I got home 10 mins later and I started to feel nauseous and dizzy I could not stand or sit in a chair.  a few hours of feeling like that I  started to vomit up clear liquid for about 20 min. Saturday I still felt dizzy and nauseous not as bad as the evening before and exhausted.  Today is Sunday and I still have  nausea.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The patient did not have any known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Positive, notes: Rebound COVID. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 13Sep2022 to 15Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a pharmacist refers to a 57 year old female patient. No information regarding the patient's medical history was provided. On 09-NOV-2013 the patient was vaccinated with PNEUMOVAX23, 0.5 ml injection, subcutaneously. No concomitant medication was reported. On an unknown date in November 2013 the patient experienced cellulitis at injection site, and injection site swelling and redness. The patient was treated at an emergency room and received "BACTRIM and pain medication". The pharmacist also mentioned that the patient developed fever blisters after receiving FLUVIRIN (not dates specified). The outcome of cellulitis at injection site, injection site was swelling and injection site redness was reported as recovering/resolving. No causality assessment was provided. Additional information has been requested.
bodyache, headache. pt presents to the ED for upper lip swelling, feeling short of breath and total body rash after administration of second COVID vaccine (02MAR2021).  HPI:35-year-old male with chief complaint of vaccine reaction.  He received a covid vaccine #2yesterday morning.  He reports headache and fatigue starting around noon.  he went home and took a nap.  He woke up around midnight and noticed rash his whole body swelling to his upper lip.he reports mild shortness of breath in addition to the headache and rash.
Runny nose Cough just felt "off"/grumpy Typical allergy symptoms gotten in the spring and fall but pollen counts were zero in my area
Nurse missed deltoid, burning and pain at time of injection. Continuing pain and shoulder stiffness 2 months past injection.
Pain in persists in upper left arm and at injection site, at times cannot lift my arm.  This morning at approximately 3:00am I woke up in extreme pain. I took a low dose aspirin in case it was a heat issue. I have also taken Tylenol for the pain.
Mom said patient developed erythema after the injection with white splotchy spots from the face and over the body. Her arm was also completely sore. She later on 11/6/16 developed nausea and vomiting with diarrhea.
Hearing Loss; This case was reported by a consumer via call center representative and described the occurrence of hearing loss in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 477S3, expiry date 5th July 2021) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 22nd July 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 22nd July 2019, 2 hrs 30 min after receiving Shingrix and 61 days after receiving Shingrix, the patient experienced hearing loss (serious criteria GSK medically significant). On 22nd July 2019, the outcome of the hearing loss was recovered/resolved.   It was unknown if the reporter considered the hearing loss to be related to Shingrix.  Additional details were provided as follows: The patient received vaccine on left arm. The patient and her husband were watching TV and she noticed she had trouble hearing a show. Hearing loss reportedly lasted 2.5 hours. The patient had supporting documentation of hearing loss. The reporter consented to follow up.
1st shot Covid Moderna was given to kid younger than 18 years old at the health clinic by error.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with ZOSTAVAX dose 1, 0.65 ml, subcutaneous. On an unknown date, for days after vaccination, the patient experienced 2 inch wide swollen, red area on arm at injection site. The patient did not see any medial attention. The outcome of 2 inch wide swollen, red area on arm at injection site was reported was recovered/resolved.  Additional information has been requested.
On 10/28/01 at 02:00, his temperature was 102.7F (ax). He had a fever all day. On 10/29/01, he developed a rash on extremities with a little on his trunk. He saw the MD on 10/31/01 and was told that he possibly had a virus. His temperature on 11/1/01 was 98.9F.
Pt. was walking down hallway after receiving the Gardasil vaccine. Pt fainted for about 5 seconds, was conscious and able to answer questions. Pt was guided to floor by a nurse after attended to by RNs and MDs. Pt left ambulatory
I have had 3 bloody noses lasting about a half an hour every 5 to 7 days.  I had never had a bloody nose in my life up to this vaccine.  They are hard to clot.
SORE ARM STARTING FROM 1 WEEK AFTER INJECTION AND PAIN HAS GOTTEN WORSE TO DATE
Post vax, the pt developed a generalized pruritic rash. Treated with Benadryl and prednisone. Rash resolved by 9/3/99.
10 days post smallpox vaccination (SPV) with multiple lesions around primary site on left arm.  Began about 7 days ago and have not changed much.  Feeling well.  She has some enlarged lymph nodes left axilla and redness around lesions.  Lesions are draining so that she changes the dressing bid.  Mild itching; no pain. No trauma fever, chills, chest pain, SOB.  No history of eczema, psoriasis or other skin disorder.  No history of any medical problems.  She has always been very healthy. 1. DERMATITIS DUE TO DRUGS AND MEDICINES GENERALIZED: Autoinoculation.  Appears very well.  12 pustules in the same stage on left deltoid.  Vary in size from eraser-size to 1/2 dime in a cluster 1 1/2 x 3 inches.  Tan--reports no change in color.  Mild erythema spreading 3 inches below and 1-2 inches on sides and top. Reviewed site care and need for extra caution with the excess drainage.  Good handwashing.  Medical reactive exemption for future SPV immunizations.  VAERS submitted.
On 2/14/00, hives, itching, tightness in chest, swelling of fingers and toes, started about 3-4 hours post vax. Mom spoke with DR and started Benadryl. On 2/14/00, hives continuing, no longer responding to Benadryl. Cheeks red and swollen. Fingers and toe are swollen. Rx'd prednisone and continue Benadryl.
Patient was given the primary vaccine dose of Pfizer for ages 5-11 and the patient is 14 so should have received the 12+ Comirnaty dose.  Unable to reach parent by phone x 3 so letter sent asking parent to contact us regarding the vaccine she received on 2/8/23.
muscle aches; nausea; fever, Tmax 101.7; neck ache; soreness at sight of injection; This is a spontaneous report from a non-contactable nurse. A 30-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL 3247), intramuscularly on 21Jan2021 at 09:15 AM in the Left arm at single dose for COVID-19 immunization in hospital. Medical history included hasimoto's, known allergies with peanuts. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), intramuscularly on 30Dec2020 at 08:15 AM in the Left arm at single dose for COVID-19 immunization at the age of 30-year-old. The patient experienced fever, Tmax 101.7, muscle aches, neck ache, soreness at sight of injection, nausea on 21Jan2021 at 23:30. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as result of the events included mefenamic acid (ADVIL). The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Information has been received from a nurse practitioner concerning a female (age unknown), who on 23-APR-2008 was vaccinated IM with a 0.5mL first dose of GARDASIL (Lot# 0152X).  Concomitant therapy included ORTHO TRI-CYCLEN LO.  On 23-APR-2008 several hours post vaccination the patient developed an outbreak of shingles on her chest.  The patient was seen at the office and was treated with acyclovir.  No laboratory diagnostics were performed.  At the time of the report, the patient was recovering.  No product quality complaint was involved.  Additional information has been requested.
Not eating; Fever; Body ache; Headache; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache) and FATIGUE (Fatigue) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information provided.
Breakthrough COVID pneumonia, hypoxic respiratory failure, fever, cough, fatigue, chest tightness
Information has been received from a woman in a physician's office concerning a 4 year old female who on 11/7/00 was vaccinated with a SC first dose of varicella virus vaccine live (lot #636569/0926K). It was reported that there was no illness at the time of vaccination. On 10/20/04, the patient reportedly had vaccine failure and was seen in the office with chicken pox. The outcome was unknown. It was reported that a patient was vaccinated with a dose of MMR and developed an AE (WAES0410USA02742). Follow up information has been received from a health professional. On 10/18/04, the patient experienced breakthrough chicken pox described as a papulovesicular rash, erythematous, diffuse on trunk, face, neck and legs. Subsequently, the patient recovered. Unspecified medical attention was sought. Additional information is not expected.
A week after the vaccine the injection site became red. The following day (today) it is a large, red, raised and itchy.